HEMIPROP vs SUMICHEM: Technicals Bole 'Buy', Par Kisko Milega Asli 'Dhamaka'?

BROKERAGE-REPORTS
Whalesbook Logo
AuthorVihaan Mehta|Published at:
HEMIPROP vs SUMICHEM: Technicals Bole 'Buy', Par Kisko Milega Asli 'Dhamaka'?
Overview

Geojit Investments ke expert Anand James ne Hemisphere Properties (HEMIPROP) aur Sumitomo Chemical India (SUMICHEM) dono mein technical buying signals dekhe hain. Par, HEMIPROP ke numbers thode kamzor hain jabki SUMICHEM financiallly strong lag raha hai.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Technicals kya bol rahe hain?

Geojit Investments ke chief market strategist Anand James ne do stocks, Hemisphere Properties India (HEMIPROP) aur Sumitomo Chemical India (SUMICHEM), par focus kiya hai. Charts pe dono mein buying ka signal dikh raha hai.

HEMIPROP mein Supertrend breakout hua hai aur prices higher lows bana rahi hain, jo ek uptrend ka ishara hai. Wahi, SUMICHEM mein bhi weekly Supertrend signal break hua hai aur monthly charts pe trend reversal ke signs hain.

HEMIPROP: Technicals Mast, Par Funda Weak?

Hemisphere Properties India (HEMIPROP) abhi lagbhag ₹135 ke aas paas trade kar raha hai. Anand James ke according, iska technical setup bahut achha hai - Supertrend breakout, April se higher lows aur weekly chart pe MACD crossover bhi positive hai. Lekin, jab hum fundamentals dekhte hain toh picture alag hai.

Company ka P/E ratio negative -346.76 hai (April 2026 tak), matlab company loss mein chal rahi hai. December 2025 quarter mein ₹3.24 crore ka loss hua aur March 2026 quarter mein ₹3.46 crore ka. Book value per share sirf ₹15.43 hai, jo current price se bahut kam hai.

HEMIPROP ek Government of India enterprise hai jo land monetization par kaam karti hai. Technical analysis mein kuch sell signals bhi hain jo price ko ₹96.07 se ₹119.62 tak neeche le ja sakte hain.

India ka real estate sector 2026 mein grow karega, par HEMIPROP ki financial health aur valuation bade sawaal utha rahe hain.

SUMICHEM: Funda Strong, Technicals Bhi Saath Mein!

Sumitomo Chemical India (SUMICHEM) ka outlook zyada positive lag raha hai. Stock ₹449 ke aas paas hai aur weekly Supertrend break karne wala hai. Monthly reversal candles aur MACD bearish momentum kam hone ke signs hain.

Fundamentally, company ka market cap ₹22,411.60 crore (April 2026 tak) hai aur P/E ratio 39.4 hai. Yeh P/E high lag sakta hai, par consistent profits ke wajah se justified hai.

Fiscal year 2025 mein revenue 10.71% badh kar ₹31.49 billion hua aur earnings 36.79% badh kar ₹5.05 billion ho gayi. Company debt-free hai aur iska ROE 18.81% hai.

Analysts ne 2026 ke liye target ₹440 se ₹500 diye hain, aur kuch ₹565 tak bhi dekh rahe hain. India ka chemical industry bhi 2026 mein 10.9% grow karne ka estimate hai.

ICICI Securities ne bhi 'Buy' rating di hai aur ₹515 ka target set kiya hai.

Main Risks Kya Hain?

HEMIPROP ke liye: Sabse badi problem hai iska constant loss aur negative P/E. Operational revenue bhi bahut kam hai, sirf ₹0.26 crore (December 2025 quarter mein). Bureaucratic delays bhi ho sakte hain. Iska stock technical breakout ke bawajood highly speculative hai aur kuch analysis ke hisab se 94 percent overvalued hai.

SUMICHEM ke liye: Iska valuation thoda high hai (P/E 39.4). Agar earnings growth 15.3% annual se kam hui ya global prices mein gadbad hui, toh price gir sakta hai. Global demand par bhi depend karta hai.

Aage Ka Outlook

Real estate sector grow karega, par HEMIPROP ko profits banane ke liye apni land assets ko effectively monetize karna hoga. Chemical sector bhi strong hai, aur SUMICHEM iska fayda uthane ke liye achhi position mein hai, bas valuation ko dhyan mein rakhte hue.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.